MYC and osteosarcoma: Specifically, we used a supF reporter plasmid-based system containing the human c-MYC H-DNA-forming sequence in transfection experiments conducted in wild-type and siRNA-treated (DHX9-depleted) osteosarcoma U2OS cells.